NCT04051710: A trial that was reported late by Aurobindo Pharma Ltd
This trial has reported, although it was 54 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04051710 |
|---|---|
| Title | Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate Efficacy and Safety of Beclomethasone Dipropionate Metered Dose Inhaler (Inhalation Aerosol) (0.04mg/ INH) in Male and/ or Female Subjects With Asthma |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 12, 2019 |
| Completion date | Aug. 29, 2019 |
| Required reporting date | Aug. 28, 2020, midnight |
| Actual reporting date | Oct. 22, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 54 |